Yuheng Chen

Dr. Yuheng Chen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2019 in Food & Function
Verified
Journal Article
Closed access
PDF file
XTxiufeng tang
xiufeng tang
YGYingying Gao
Yingying Gao
YCYuheng Chen
Yuheng Chen
XLXiaoxi Li
Xiaoxi Li
PYPing Yu
Ping Yu
RLRenhui Liu
Renhui Liu
Senile osteoporosis (SOP) is a related disease of systematic degenerative changes in bones during natural aging.

31 January 2023 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ZMZitong Ma
Zitong Ma
XTxiufeng tang
xiufeng tang
YCYuheng Chen
Yuheng Chen
HWHan Wang
Han Wang
YLYuman Li
Yuman Li
RLRenhui Liu
Renhui Liu
Osteoblast (OB) and osteoclast (OC) play important roles in bone formation and bone resorption, which can communicate with each other through cytokine paracrine. Previous studies have confirmed that Epimedii Folium (EF) and Ligustri Lucidi Fructus (LLF) used alone or in combination can treat osteoporosis (OP) through regulating bone remodeling, but the effects of EF and LLF on osteoblastogenesis, osteoclastogenesis, and OB-OC communication are unclear. In this study, we investigated the direct and indirect effects of EF and LLF on OBs and OCs via monoculture and coculture (transwell) models of OBs and OCs. We found that the combination of EF and LLF (EFLLF) could promote osteoblastogenesis and inhibit osteoclastogenesis directly and indirectly. In order to study the mechanisms of EFLLF on indirectly regulating osteoblastogenesis and osteoclastogenesis, we detected the expression of cytokines by which OBs and OCs could communicate with each other. We found that EFLLF could downregulate the expression of RANKL and M-CSF and the protein ratio of RANKL/OPG of OBs and Atp6v0d2 expression of OCs and upregulate the expression of OPG and TGF-β1 of OBs and the expression of TGF-β1, BMP-2, and IGF-1 of OCs, indicating that EFLLF could regulate cytokine expressions of OBs/OCs to affect OB-OC communication. In addition, EFLLF had a better effect on regulating cytokines of OBs and OCs than EF or LLF in single use. This study suggested that EFLLF exhibited the effects of promoting osteoblastogenesis and inhibiting osteoclastogenesis via acting on OB-OC communication and provided some scientific evidences for EFLLF against OP.

13 February 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YCYuheng Chen
Yuheng Chen
XLXiaoxi Li
Xiaoxi Li
XTxiufeng tang
xiufeng tang
YGYingying Gao
Yingying Gao
PYPing Yu
Ping Yu
RLRenhui Liu
Renhui Liu
This study aimed to investigate the osteoprotective effect and the possible molecular mechanisms of the combined extracts of Herba Epimedii and Fructus Ligustri Lucidi on postmenopausal osteoporosis (PMOP). Forty-eight female SD rats were sham-operated (Sham, n = 8) or ovariectomized (OVX, n = 40). Then after a week, OVX rats were divided randomly into five groups (n = 8 in each group): OVX, extracts of Herba Epimedii (HE, 0.35 g/kg), extracts of Fructus Ligustri Lucidi (FLL, 0.35 g/kg), combined extracts of HE and FLL (HE & FLL, 0.20 g/kg HE plus 0.15 g/kg FLL), and Raloxifene hydrochloride (RH, 6.25 mg/kg) groups. All groups were administered once daily for 12 weeks. Indicators related to bone remodeling were detected, including estradiol (E2), bone mineral density (BMD), maximal load, ultimate deflection, micro-CT properties, tartrate-resistant acid phosphatase (TRACP) and alkaline phosphatase (ALP) levels in serum and bone, and the protein and mRNA expression of bone turnover markers (RANKL, M-CSF, Wnt5a, Atp6v0d2, OPG, IGF-1, TGF-β1, and Bmp-2). Results showed that the combined extracts could increase serum E2 levels and BMD, enhance bone strength, reserve bone microstructure degeneration, promote bone formation, and inhibit bone resorption through upregulating the mRNA and protein expression of OPG, IGF-1, TGF-β1, and Bmp-2, while downregulating RANKL, M-CSF, Wnt5a, and Atp6v0d2. These findings demonstrated that the combined extracts of Herba Epimedii and Fructus Ligustri Lucidi with bone protective effects on OVX rats might be an alternative medicine for the treatment of PMOP.

2 January 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
XTxiufeng tang
xiufeng tang
XLXiao-Xi Li
Xiao-Xi Li
YCYuheng Chen
Yuheng Chen
YGYing-Ying Gao
Ying-Ying Gao
PYPing Yu
Ping Yu
RLRenhui Liu
Renhui Liu
Glucocorticoid resistance (GCR) remains a significant problem and is the most important reason for treatment failure of glucocorticoids (GCs). How to increase the sensitivity to GCs and exploring new agents to overcome GCR is of great significance. Herein, we report for the first time that the effects of combination of icariin and oleanolic acid (OA) on dexamethasone (Dex)-induced glucocorticoid receptor (GR) impairment in vivo and in vitro. Compared with the use of Dex or combination of icariin and OA alone, co-administration resulted in a significant increase in apoptosis, GR protein, GR binding and GRα protein both in GC-sensitive CEM-C7 and GC-resistant CEM-C1 cells and a decrease in GRβ protein and GRβ/GRα only in CEM-C1 cells. Furthermore, an ovalbumin-induced rat asthma model was chosen to evaluate the effects of co-administration of Dex and combination of icariin and OA in vivo. Compared with the use of Dex alone, co-administration could protect blood lymphocyte from excessive apoptosis, significantly increasing GR binding, GR protein and mRNA of GRα while decreasing GRβ protein and mRNA of GRβ. The results suggested that combination of icariin and OA could increase sensitivity to GCs through attenuating in vivo and in vitro Dex-induced GR impairment.